M Berger

Cancer vaccines: the interleukin 2 dosage effect.

Wolfgang Schmidt, Tamás Schweighoffer, E Herbst et al. · Proceedings of the National Academy of Sciences · 1995 · 127 citations · Full text

Immunology, Immunologic Mechanism, Protection Efficiency +17

Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination.

Gerd Maass, Wolfgang Schmidt, M Berger et al. · Proceedings of the National Academy of Sciences · 1995 · 95 citations · Full text

Immunology, Immunologic Mechanism, Immunotherapy +17

Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parameters.

Kurt Zatloukal, Achim Schneeberger, M Berger et al. · The Journal of Immunology · 1995 · 88 citations

Immunology, Immunoediting, Il-2 Gene Construct +18

In vivo production of human factor VII in mice after intrasplenic implantation of primary fibroblasts transfected by receptor-mediated, adenovirus-augmented gene delivery.

Kurt Zatloukal, Matthew Cotten, M Berger et al. · Proceedings of the National Academy of Sciences · 1994 · 72 citations · Full text

Cell Therapy, In Vivo Gene Therapy, Immunology +20

Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer.

Kenneth W. Culver, William Osborne, A. Dusty Miller et al. · PubMed · 1991 · 64 citations

Primary Immunodeficiency, Allergy, Human T +7